Drug intelligence / Profile preview

iodine I-125

Development stage
Unknown
Lead developer
IsoAid
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Implant, Percutaneous
01

Overview

Iodine-125 seeds are small, titanium-encapsulated radioactive sources containing the radioisotope Iodine-125. In the context of breast cancer surgery, they are primarily used for **Radioactive Seed Localization (RSL)** to mark non-palpable lesions or metastatic lymph nodes (Targeted Axillary Dissection). The seed emits low-energy gamma radiation (approximately 27-35 keV), which can be detected intraoperatively using a handheld gamma probe, allowing surgeons to precisely locate and excise the marked tissue. Beyond localization, these seeds are also widely used in **permanent brachytherapy** for the treatment of localized prostate cancer, where they are implanted directly into the tumor to deliver a localized dose of radiation over several months as the isotope decays (half-life of approximately 59.4 days).

Brand names
AdvantageEchoSeedOncoSeedSelectSeedI-125 SeedI125 SeedI 125 Seed
Other names
iodine-125 seediodine125 seediodine 125 seedradioactive iodine seedI-125I125I 125iodine (125I)
02

Targets

DNA

Beyond the preview

Go deeper on iodine I-125.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine I-125.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call